Edition:
United States

Shilpa Medicare Ltd (SHME.NS)

SHME.NS on National Stock Exchange of India

415.45INR
6:27am EDT
Change (% chg)

Rs3.95 (+0.96%)
Prev Close
Rs411.50
Open
Rs413.40
Day's High
Rs427.80
Day's Low
Rs411.45
Volume
42,816
Avg. Vol
56,412
52-wk High
Rs716.80
52-wk Low
Rs398.30

Chart for

About

Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation. The Company's segments include Bulk Drug/Intermediates and Energy. It offers 3a 7b Dihydroxy. The Company deals with APIs, Intermediates, Formulations, New Drug... (more)

Overall

Beta: 0.44
Market Cap(Mil.): Rs35,716.93
Shares Outstanding(Mil.): 81.53
Dividend: 0.70
Yield (%): 0.17

Financials

  SHME.NS Industry Sector
P/E (TTM): 28.44 28.56 32.59
EPS (TTM): 14.47 -- --
ROI: -- 13.05 12.60
ROE: -- 14.79 14.49

BRIEF-India's Shilpa Medicare ‍Declared Interim Dividend Of 0.70 Rupees Per Shr

* ‍DECLARED INTERIM DIVIDEND OF 0.70 RUPEES PER EQUITY SHARE​ Source text - http://bit.ly/2sKO9xj Further company coverage:

Feb 22 2018

BRIEF-India's Shilpa Medicare Dec-Qtr Consol Profit Falls

* DEC QUARTER CONSOL PROFIT 163.4 MILLION RUPEES VERSUS PROFIT OF 170.5 MILLION RUPEES YEAR AGO

Feb 13 2018

BRIEF-India's Shilpa Medicare Says U.S. FDA Issues 3 483 Observations To Co's Karnataka Units

* US FDA COMPLETED INSPECTION OF CO'S API FACILITIES UNIT-I AND UNIT-II LOCATED AT RAICHUR, KARNATAKA

Jan 22 2018

BRIEF-Shilpa Medicare Gets 483 Observations From U.S. FDA For SEZ Formulation Facilities In Telangana

* SAYS GOT 483 OBSERVATIONS FROM U.S. FDA IN RELATION TO SEZ FORMULATION FACILITIES SITUATED AT JADCHERLA, TELANGANA

Dec 05 2017

Earnings vs. Estimates